Request completed
Thank you for confirming your registration.
You can revoke this at any time via the “unsubscribe” link in every e-mail received.
We will verify your request and – should you fulfill the requirements* – will provide you with the information you requested in due time.
Best regards
Your FCF Team
*All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request.
NEWS & PRESS
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2023”. The Monitor is a monthly published overview of venture capital trends in the European
FCF @Health Tech Forward 2023 in Warsaw on November 28. – 29.
FCF is excited to announce the participation of Johannes Link, Associate, and a valuable member of our Life Sciences team, at the Health Tech Challengers event during the Health Tech Forward conference. This event takes
Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million.
PRESS RELEASE Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million. Munich, November 6, 2023 – FCF Fox Corporate Finance, a
FCF Valuation Monitor – Q3 2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q3 2023”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
„Ace the Case“ with FCF & Celonis @TUM Case Club in Munich
The „Ace the Case“ event took place on November, 2nd, 2023, at the TUM Case Club in Munich. The “Ace the Case” event took place on November 2nd, 2023, at the TUM Case Club in
